Product Recalls in South Dakota

Product recalls affecting South Dakota — including food, drugs, consumer products, medical devices, and vehicles distributed to South Dakota. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,554 recalls have been distributed to South Dakota in the last 12 months.

47,632 total recalls
2,554 in last 12 months

Showing 721740 of 13,354 recalls

DrugJanuary 22, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Carvedilol Tablets Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: CGMP Deviations:N-Nitroso Carvedilol I impurity (NNCI-I) were found to be...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 21, 2025· The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Recalled Item: Lorazepam Tablets Recalled by The Harvard Drug Group LLC dba Major...

The Issue: Failed impurities/degradation specifications and Sub-potent Drug:...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 21, 2025· Provepharm Inc.

Recalled Item: Phenylephrine HCl Injection Recalled by Provepharm Inc. Due to Presence of...

The Issue: Presence of Particulate Matter.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugJanuary 21, 2025· The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Recalled Item: Lorazepam Tablets Recalled by The Harvard Drug Group LLC dba Major...

The Issue: Failed impurities/degradation specifications and Sub-potent Drug:...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 21, 2025· The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Recalled Item: Lorazepam Tablets Recalled by The Harvard Drug Group LLC dba Major...

The Issue: Failed impurities/degradation specifications and Sub-potent Drug:...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 21, 2025· AvKARE

Recalled Item: Irbesartan Tablets USP Recalled by AvKARE Due to Out of Specification for...

The Issue: Out of Specification for Dissolution

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 17, 2025· The W.S. Badger Company, Inc.

Recalled Item: BADGER 50 Recalled by The W.S. Badger Company, Inc. Due to Labeling: Missing...

The Issue: Labeling: Missing Label: The finished product potentially missing the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJanuary 17, 2025· McKesson

Recalled Item: Inflectra (infliximab-dyyb) Recalled by McKesson Due to cGMP Deviations:...

The Issue: cGMP Deviations: Product intended for quarantine was inadvertently distributed.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 16, 2025· Appco Pharma LLC

Recalled Item: Venlafaxine Extended-Release Tablets Recalled by Appco Pharma LLC Due to...

The Issue: Failed Tablet/Capsule Specifications: Missing tab ID on either side of the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJanuary 13, 2025· The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Recalled Item: Duloxetine Delayed-Release Capsules USP Recalled by The Harvard Drug Group...

The Issue: CGMP Deviations: presence of Nitrosamine Drug Substances Related Impurity...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 10, 2025· Teva Pharmaceuticals USA, Inc

Recalled Item: Granix (tbo-filgrastim) Injection 300 mcg/0.5 mL Recalled by Teva...

The Issue: Failed Stability Specifications - 12-month stability test result for one of...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 8, 2025· Johnson, S C and Son, Inc

Recalled Item: babyganics Recalled by Johnson, S C and Son, Inc Due to Failed stability...

The Issue: Failed stability specifications: during routine stability monitoring quality...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 7, 2025· Amerisource Health Services LLC

Recalled Item: Clobazam Tablets Recalled by Amerisource Health Services LLC Due to Presence...

The Issue: Presence of Foreign Tablets/Capsules

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 30, 2024· Rising Pharma Holding, Inc.

Recalled Item: Duloxetine Delayed-Release Capsules USP 30 mg Recalled by Rising Pharma...

The Issue: CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 30, 2024· Rising Pharma Holding, Inc.

Recalled Item: Duloxetine DR Capsules USP 60 mg Recalled by Rising Pharma Holding, Inc. Due...

The Issue: CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 30, 2024· Rising Pharma Holding, Inc.

Recalled Item: Duloxetine Delayed-Release Capsules USP 20 mg Recalled by Rising Pharma...

The Issue: CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 27, 2024· Eugia US LLC

Recalled Item: Progesterone Injection USP Recalled by Eugia US LLC Due to Presence of...

The Issue: Presence of Particulate Matter: A market complaint was received of a glass...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 23, 2024· Astellas Pharma US Inc.

Recalled Item: Prograf (tacrolimus) capsules Recalled by Astellas Pharma US Inc. Due to...

The Issue: Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugDecember 23, 2024· Astellas Pharma US Inc.

Recalled Item: Astagraf XL (tacrolimus extended-release capsules) 0.5 mg Recalled by...

The Issue: Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugDecember 23, 2024· First Aid Beauty Ltd

Recalled Item: First Aid Beauty Ultra Repair Cream Recalled by First Aid Beauty Ltd Due to...

The Issue: CGMP Deviations; product intended for quarantine was inadvertently distributed

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund